efficacy of sublingual semaglutide Oral versus subcutaneous liraglutide and placebo in type 2 diabetes (PIONEER 4): a randomised, double-blind, phase 3a trial protocol:bariatric-pureed Dose:1.50 mg Melissa Ann Butler |

efficacy of sublingual semaglutide Oral versus subcutaneous liraglutide and placebo in type 2 diabetes (PIONEER 4): a randomised, double-blind, phase 3a trial protocol:bariatric-pureed Dose:1.50 mg Melissa Ann Butler |

Melissa Ann Butler | GLP-1 doesn't fail people. People fail when they're not given the right tools. Doctors prescribe GLP-1 to help patients improve their... | Instagram

In STEP 10, mean weight loss on Wegovy was 13.9% at 52 weeks, and 81% of participants returned to healthy blood sugar levels

protocol:bariatric-pureed

Dose:1.50 mg

When thyroid function is controlled with antithyroid medications, radioactive iodine, or surgery, many patients experience weight gain